Prenatal dexamethasone programs expression of genes in liver and adipose tissue and increased hepatic lipid accumulation but not obesity on a high-fat diet

Endocrinology

Volumn 151, Issue 4, 2010, Pages 1581-1587

  Drake, Amanda J ^a   Raubenheimer, Peter J ^a   Kerrigan, David ^a   McInnes, Kerry J ^a   Seckl, Jonathan R ^a   Walker, Brian R ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACYL[ACYL CARRIER PROTEIN] PHOSPHOLIPID ACYLTRANSFERASE; ACYLTRANSFERASE; CYCLOPHILIN; DEXAMETHASONE; DIACYLGLYCEROL ACYLTRANSFERASE; DIACYLGLYCEROL ACYLTRANSFERASE 1; DIACYLGLYCEROL ACYLTRANSFERASE 2; FAS ANTIGEN; FATTY ACID; GLUCOSE; HORMONE SENSITIVE LIPASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE 1; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE 2; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; TATA BINDING PROTEIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; UNCOUPLING PROTEIN 2;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ARTICLE; BODY COMPOSITION; BODY FAT DISTRIBUTION; CATCH UP GROWTH; CONTROLLED STUDY; ESTERIFICATION; FATTY ACID METABOLISM; FEMALE; GENE EXPRESSION; GENE FUNCTION; GESTATIONAL AGE; HYPERINSULINEMIA; INSULIN SENSITIVITY; LIPID BLOOD LEVEL; LIPID DIET; LIPID LIVER LEVEL; LIPID METABOLISM; LIPID STORAGE; LIPOGENESIS; LOW BIRTH WEIGHT; MALE; NONHUMAN; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PERINATAL PERIOD; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; RAT;

ADIPOSE TISSUE; AMP-ACTIVATED PROTEIN KINASES; ANALYSIS OF VARIANCE; ANIMALS; ANIMALS, NEWBORN; BIRTH WEIGHT; BLOOD GLUCOSE; BLOTTING, WESTERN; DEXAMETHASONE; FATTY LIVER; FEMALE; GENE EXPRESSION REGULATION; GLUCOCORTICOIDS; GLUCOSE TOLERANCE TEST; INSULIN; LIVER; MALE; OBESITY; ORGAN SIZE; PHOSPHORYLATION; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRIGLYCERIDES;

EID: 77950204178     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2009-1088     Document Type: Article

References (34)

1. Barker DJP 1998 In utero programming of chronic disease. Clin Sci 95:115-128
2. Ibáñez L, Lopez-Bermejo A, Suárez L, Marcos MV, Díaz M, de Zegher F 2008 Visceral adiposity without overweight in children born small for gestational age. J Clin Endocrinol Metab 93:2079-2083
3. Ibáñez L, Suárez L, Lopez-Bermejo A, Díaz M, Valls C, de Zegher F 2008 Early development of visceral fat excess after spontaneous catch-up growth in children with low birth weight. J Clin Endocrinol Metab 93:925-928
4. Rasmussen F, Johansson M 1998 The relation of weight, length and ponderal index at birth to body mass index and overweight among 18-year-old males in Sweden. Eur J Epidemiol 14:373-380
5. Eriksson M, Tynelius P, Rasmussen F 2008 Associations of birthweight and infant growth with body composition at age 15-the COMPASS study. Paediatr Perinat Ep 22:379-388
6. Lithell HO, McKeigue PM, Berglund L, Mohsen R, Lithell UB, Leon DA 1996 Relation of size at birth to non-insulin dependent diabetes and insulin concentrations in men aged 50-60 years. Brit Med J 312:406-410
7. Yajnik CS 2002 The lifecycle effects of nutrition and body size on adult adiposity, diabetes and cardiovascular disease. Obes Rev 3:217-224
8. Leon DA, Koupilova I, Lithell HO, Berglund L, Mohsen R, Vagero D, Lithell UB, McKeigue PM 1996 Failure to realise growth potential in utero and adult obesity in relation to blood pressure in 50 year old Swedish men. Brit Med J 312:401-406
9. Barker DJ, Osmond C, Forsén TJ, Kajantie E, Eriksson JG 2005 Trajectories of growth among children who have coronary events as adults. New Engl J Med 353:1802-1809
10. Benediktsson R, Lindsay RS, Noble J, Seckl JR, Edwards CR 1993 Glucocorticoid exposure in utero: new model for adult hypertension. Lancet 341:339-341
11. Nyirenda MJ, Lindsay RS, Kenyon CJ, Burchell A, Seckl JR 1998 Glucocorticoid exposure in late gestation permanently programs rat hepatic phosphoenolpyruvate carboxykinase and glucocorticoid receptor expression and causes glucose intolerance in adult offspring. J Clin Invest 101:2174-2181
12. Lindsay RS, Lindsay RM, Edwards CR, Seckl JR 1996 Inhibition of 11-β-hydroxysteroid dehydrogenase in pregnant rats and the programming of blood pressure in the offspring. Hypertension 27:1200-1204
13. Cleasby ME, Kelly PA, Walker BR, Seckl JR 2003 Programming of rat muscle and fat metabolism by in utero over-exposure to glucocorticoids. Endocrinology 144:999-1007
14. Welberg LA, Seckl JR, Holmes MC 2001 Prenatal glucocorticoid programming of brain corticosteroid receptors and corticotrophinreleasing hormone: possible implications for behaviour. Neuroscience 104:71-79
15. Drake AJ, Livingstone DE, Andrew R, Seckl JR, Morton NM, Walker BR 2005 Reduced adipose glucocorticoid reactivation and increased hepatic glucocorticoid clearance as an early adaptation to high-fat feeding in Wistar rats. Endocrinology 146:913-919
16. Drake AJ, Walker BR, Seckl JR 2005 Intergenerational consequences of fetal programming by in utero exposure to glucocorticoids in rats. Am J Physiol 288:R34-R38
17. Marceau P, Biron S, Hould FS, Marceau S, Simard S, Thung SN, Kral JG 1999 Liver pathology and the metabolic syndrome X in severe obesity. J Clin Endocrinol Metab 84:1513-1517
18. Marchesini G, Brizi M, Bianchi G, Tomassetti S, Bugianesi E, Lenzi M, McCullough AJ, Natale S, Forlani G, Melchionda N 2001 Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 50:1844-1850
19. Pagano G, Pacini G, Musso G, Gambino R, Mecca F, Depetris N, Cassader M, David E, Cavallo-Perin P, Rizzetto M 2002 Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association. Hepatology 35:367-372
20. Anderson N, Borlak J 2008 Molecular mechanisms and therapeutic targets in steatosis and steatohepatitis. Pharmacol Rev 60:311-357
21. Yu S, Matsusue K, Kashireddy P, Cao WQ, Yeldandi V, Yeldandi AV, Rao MS, Gonzalez FJ, Reddy JK 2003 Adipocyte-specific gene expression and adipogenic steatosis in the mouse liver due to peroxisome proliferator-activated receptor γ 1 (PPARγ 1) overexpression. J Biol Chem 278:498-505
22. Gavrilova O, Haluzik M, Matsusue K, Cutson JJ, Johnson L, Dietz KR, Nicol CJ, Vinson C, Gonzalez FJ, Reitman ML 2003 Liver peroxisome proliferator-activated receptor γ contributes to hepatic steatosis, triglyceride clearance, and regulation of body fat mass. J Biol Chem 278:34268-34276
23. Magee TR, Han G, Cherian B, Khorram O, Ross MG, Desai M 2008 Down-regulation of transcription factor peroxisome proliferatoractivated receptor in programmed hepatic lipid dysregulation and inflammation in intrauterine growth-restricted offspring. Am J Obstet Gynecol 199:271.e1-5
24. Seo YS, Kim JH, Jo NY, Choi KM, Baik SH, Park J-J, Kim JS, Byun KS, Bak Y-T, Lee CH, Kim A, Yeon JE 2008 PPAR agonists treatment is effective in a nonalcoholic fatty liver disease animal model by modulating fatty-acid metabolic enzymes. J Gastroen Hepatol 23:102-109
25. Leone TC, Lehman JJ, Finck BN, Schaeffer PJ, Wende AR, Boudina S, Courtois M, Wozniak DF, Sambandam N, Bernal-Mizrachi C, Chen Z, Holloszy JO, Medeiros DM, Schmidt RE, Saffitz JE, Abel ED, Semenkovich CF, Kelly DP 2005 PGC-1α deficiency causes multi-system energy metabolic derangements: muscle dysfunction, abnormal weight control and hepatic steatosis. PLoS Biol 3:e101
26. Estall JL, Kahn M, Cooper MP, Fisher FM, Wu MK, Laznik D, Qu L, Cohen DE, Shulman GI, Spiegelman BM 2009 Sensitivity of lipid metabolism and insulin signaling to genetic alterations in hepatic peroxisome proliferator-activated receptor-γ coactivator-1α expression. Diabetes 58:1499-1508
27. Westerbacka J, Kolak M, Kiviluoto T, Arkkila P, Sirén J, Hamsten A, Fisher RM, Yki-Järvinen H 2007 Genes involved in fatty acid partitioning and binding, lipolysis, monocyte/macrophage recruitment, and inflammation are overexpressed in the human fatty liver of insulin-resistant subjects. Diabetes 56:2759-2765
28. Medina-Gomez G, Gray S, Vidal-Puig A 2007 Adipogenesis and lipotoxicity: role of peroxisome proliferator-activated receptor γ (PPARγ) and PPARγcoactivator-1 (PGC1). Public Health Nutr 10:1132-1137
29. Chen N, Liu L, Zhang Y, Ginsberg HN, Yu YH 2005 Whole-body insulin resistance in the absence of obesity in FVB mice with overexpression of Dgat1 in adipose tissue. Diabetes 54:3379-3386
30. Shimomura I, Hammer RE, Richardson JA, Ikemoto S, Bashmakov Y, Goldstein JL, Brown MS 1998 Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue: model for congenital generalized lipodystrophy. Gene Dev 15:3182-3194
31. Shimano H, Shimomura I, Hammer RE, Herz J, Goldstein JL, Brown MS, Horton JD 1997 Elevated levels of SREBP-2 and cholesterol synthesis in livers of mice homozygous for a targeted disruption of the SREBP-1 gene. J Clin Invest 100:2115-2124
32. Soukas A, Cohen P, Socci ND, Friedman JM 2000 Leptin-specific patterns of gene expression in white adipose tissue. Gene Dev 14:963-980
33. Erickson SK 2009 Nonalcoholic fatty liver disease. J Lipid Res 50:S412-S416
34. Fraser A, Ebrahim S, Smith GD, Lawlor DA 2008 The associations between birthweight and adult markers of liver damage and function. Paediatr Perinat Ep 22:12-21